Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD)
Abstract: Non-alcoholic fatty liver disease (NAFLD) is a prevailing health challenge that requires urgent innovative interventions. This review explores the role of nanotechnology as a promising potential in the treatment of NAFLD. It delineates the limitations of the current management strategies for NAFLD and highlights the new nanotechnology-based treatments including nanoemulsions, liposomes, micelles, polymeric nanoparticles, nanogels, inorganic nanoparticles, and zinc oxide nanoparticles. Despite the optimism surrounding the nanotechnological approach, the review underscores the need to address the limitations such as technical challenges, potential toxicity, and ethical considerations that impede the practical application of nanotechnology in NAFLD management. It advocates for collaborative efforts from researchers, clinicians, ethicists, and policymakers to achieve safe, effective, and equitable nanotechnology-based treatments for NAFLD. https://www.excli.de/excli/article/view/6420
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease (NAFLD) ; volume:22 ; year:2023
EXCLI journal ; 22 (2023)
- Creator
-
Moghtadaie, Atie
Mahboobi, Hamidreza
Fatemizadeh, Somayeh
Kamal, Mohammad Amjad
- DOI
-
10.17179/excli2023-6420
- URN
-
urn:nbn:de:101:1-2501170215307.216519114427
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moghtadaie, Atie
- Mahboobi, Hamidreza
- Fatemizadeh, Somayeh
- Kamal, Mohammad Amjad
Other Objects (12)
Korrelation von Apolipoprotein C3 und non-alcoholic fatty liver disease (NAFLD)
Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Indices to represent cross-sectional non-alcoholic fatty liver disease (NAFLD) and longitudinal NAFLD development during lifestyle interventions
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet
Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
Korrelation von Apolipoprotein C3 und non-alcoholic fatty liver disease (NAFLD)
Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Indices to represent cross-sectional non-alcoholic fatty liver disease (NAFLD) and longitudinal NAFLD development during lifestyle interventions
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet
Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
Korrelation von Apolipoprotein C3 und non-alcoholic fatty liver disease (NAFLD)
Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Indices to represent cross-sectional non-alcoholic fatty liver disease (NAFLD) and longitudinal NAFLD development during lifestyle interventions
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet
Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)